Ben Towne Center for Childhood Cancer Research

The Ben Towne Center’s mission is to translate scientific discoveries into innovative therapies that cure childhood cancer with minimal side effects and improve survivors’ quality of life.

Our Vision

We are spearheading treatments that use the immune system to eliminate cancer, without chemotherapy or radiation. Our goal is to render today’s therapies obsolete until treating childhood cancer is no different than treating an everyday virus.

Accelerating Progress Toward Cures

  • Goal: Cure Neuroblastoma

    Dr. Julie Park is leading one of the world’s first clinical studies of immunotherapy for neuroblastoma – the deadliest childhood cancer.

  • We Need Your Help

    You can help bring an end to childhood cancer all over the world, by supporting our Strong Against Cancer fundraising initiative.

Participate in Research

Our researchers have started the first round of clinical trials exploring a potential cure.

Help us answer questions about childhood health and illness, and help other children in the future. Learn more.


Developing groundbreaking cancer treatments takes more than just the right ideas. It also takes the right people.

Please visit Seattle Children’s careers page to learn about current openings.

For information about potential opportunities in the Ben Towne Center, email us.

Latest News

Graft Versus Host Disease Battle12.27.2017 – Ivanhoe
Stem cell transplants can be the best hope for a cure from diseases like leukemia. Too often, rejection, or graft versus host disease (GVHD) follows, and it can be deadlier than the original disease. A researcher in Seattle is encouraged by a new combination of therapies that may prevent GVHD altogether. Childhood cancer researcher Dr. Leslie Kean, associate director, Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute has worked her entire career to find something to prevent GVHD.

The future of immunotherapy treatment for pediatric cancers1.31.2018 – Children’s Hospitals Today
Over the last several years, immunotherapy has emerged as a promising alternative to traditional forms of cancer treatment. Seattle Children's Hospital is at the forefront of these efforts, with several trials underway to better treat leukemia in children and young adults by boosting the immune system with T-cell immunotherapy. Researchers hope T-cell therapy will transform care for some childhood cancers, making treatment more effective, in less time and with milder side effects. Children's Hospitals Today caught up with Dr. Michael Jensen, director of the Ben Towne Center for Childhood Cancer Research at Seattle Children's, to gather his perspectives on the future of immunotherapy treatment for pediatric cancers.

In the future, cancer treatment may be remote controlled2.6.2018 – Healthline
In the future, fighting cancer may no longer mean grueling chemotherapy, but genetically altered immune systems that can be “remote controlled.” That’s currently the hope of researchers based at the University of California, San Diego, who are investigating if ultrasound waves can manipulate immune system T cells to effectively create a new form of cancer treatment. Dr. Rebecca Gardner, an oncologist at Seattle Children’s Hospital, said this study is a “pretty nifty idea.” “What’s really unique about this study is that it’s anatomically specific,” said Gardner, who’s also a principal investigator of two CAR T-cell immunotherapy clinical trials at Seattle Children’s. “You have to have the ultrasound machine that goes to where the CAR T cells are and turns them on only in that location.”